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Introduction
The lumen of the ER enables proteins to fold properly before 
they are transported along the secretory pathway (Ellgaard and 
Helenius, 2003). When proteins misfold, the ER quality con-
trol system ensures that they are retained in the ER to prevent 
them from reaching their fi  nal destination and/or to allow for 
their refolding. Irreversibly misfolded proteins are eliminated 
by retrotranslocation to the cytosol, where they are ubiqui-
tinated and degraded by the proteasome (for review see Tsai 
et al., 2002). The ER factors facilitating these opposing re-
actions are largely unknown.
We used cholera toxin (CT), which is secreted by the 
bacterium  Vibrio cholerae, to study retrotranslocation. CT 
consists of a receptor-binding homopentameric B subunit that 
is noncovalently associated with a single catalytic A subunit. 
Once CT is secreted from V. cholerae, the A subunit is cleaved 
into the A1 toxic domain and the A2 domain, which are con-
nected by a disulfi  de bond and other noncovalent interactions. 
To intoxicate cells, the holotoxin is endocytosed and travels 
from the plasma membrane to the ER lumen (Fujinaga et al., 
2003). In the ER, the A subunit is disguised as a misfolded pro-
tein and hijacks the retrotranslocation machinery so that the A1 
chain reaches the cytosol, where it is resistant to proteasomal 
degradation (Rodighiero et al., 2002), whereas the B subunit 
remains in the ER (Fujinaga et al., 2003). In the cytosol, the A1 
peptide activates a cAMP-dependent signal cascade that results 
in chloride and water secretion, leading to diarrhea (Sears and 
Kaper, 1996). Elucidating the ER–cytosol transport mecha-
nism of CT will not only clarify a decisive step in toxin traf-
fi  cking but will also clarify the retrotranslocation mechanism 
of misfolded proteins.
Previous in vitro analysis found that the ER oxidoreduc-
tase protein disulfi  de isomerase (PDI) unfolds the A and A1 
chains of CT (Tsai et al., 2001), a reaction we believe prepares 
the toxin for retrotranslocation. The PDI-like protein ERp29 has 
also been implicated in protein unfolding reactions   (Magnuson 
et al., 2005). However, PDI family proteins have also been 
shown to facilitate protein folding (for review see Wilkinson and 
  Gilbert, 2004). Thus, it is possible that certain PDI-like proteins 
are   dedicated to the retention and refolding of misfolded poly-
peptides, whereas other PDI family members function to unfold 
misfolded proteins in preparation for their retrotranslocation.
In this study, we developed a semipermeabilized cell sys-
tem that monitors the ER–cytosol transport of CT and found 
that PDI facilitates the toxin’s retrotranslocation, whereas ERp72, 
a PDI-like protein, mediates its ER retention. Furthermore, 
these activities were found to operate on endogenous ER 
  misfolded proteins, indicating the generality of this mechanism. 
These results identify PDI family members as playing opposite 
roles in ER quality control and establish an assay to elucidate 
the retrotranslocation process of CT.
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M
isfolded proteins in the endoplasmic reticulum (ER) 
are retained in the organelle or retrotranslocated 
to the cytosol for proteasomal degradation.
ER chaperones that guide these opposing processes are 
largely unknown. We developed a semipermeabilized 
cell system to study the retrotranslocation of cholera toxin 
(CT), a toxic agent that crosses the ER membrane to reach 
the cytosol during intoxication. We found that protein 
  disulﬁ  de isomerase (PDI) facilitates CT retrotranslocation, 
whereas ERp72, a PDI-like protein, mediates its ER retention. 
In vitro analysis revealed that PDI and ERp72 alter 
CT’s conformation in a manner consistent with their roles 
in retrotranslocation and ER retention. Moreover, we 
found that PDI’s and ERp72’s opposing functions operate 
on endogenous ER misfolded proteins. Thus, our data 
identify PDI family proteins that play opposing roles in ER 
quality control and establish an assay to further delineate 
the mechanism of CT retrotranslocation.
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Results and discussion
Retrotranslocation of CT
To study CT retrotranslocation, we developed an assay that 
monitors the transport of the A and A1 subunits from the ER 
into the cytosol, taking advantage of a semipermeabilized cell 
assay that effi  ciently separates cytosolic from ER proteins 
(Le Gall et al., 2004). CT-intoxicated HeLa cells were treated 
with 0.04% digitonin to permeabilize the plasma membrane 
and were fractionated by centrifugation. The supernatant 
should contain cytosolic proteins as well as ER–cytosol-
  transported CT, whereas the pellet should contain the plasma 
membrane, intracellular organelles (including the ER), and 
toxin that did not undergo retrotranslocation. We tested the 
purity of these fractions and found the ER resident protein 
ERp57 to be entirely in the pellet (Fig. 1 A, second panel from 
bottom; lanes 2, 4, and 6) and the cytosolic protein Hsp90 to 
be mostly in the supernatant (Fig. 1 A, bottom; lanes 1, 3, and 5). 
When cells were intoxicated with CT at 37°C, a portion of 
the A1 subunit was found in the supernatant (Fig. 1 A, top; 
compare lane 6 with 5), whereas the B subunit was absent in 
this fraction (Fig. 1 A, second panel from top; compare odd 
with even lanes) as expected. Typically, 15–30% of toxin and 
<0.01% of ER resident proteins was detected in the superna-
tant (calculation not depicted), indicating that the presence of 
the toxin in this fraction is not caused by ER leakage. This 
range is likely caused by the variable effi  ciency of the low 
level of detergent used in this study in permeabilizing the 
plasma membrane.
When cells were incubated with CT at 4 or at 37°C in the 
presence of brefeldin A (BFA), which are conditions shown pre-
viously to block the arrival of CT to the ER (Fujinaga et al., 
2003), the A1 chain did not appear in the supernatant (Fig. 1 A, 
top; compare lane 5 with 1 and 3). A fraction of the A1 peptide 
in the pellet was generated after lysis, as cell permeabilization 
in the presence of the alkylating reagent N-ethylmaleimide 
(NEM) diminished the appearance of the A1 chain (Fig. 1 A, 
compare lane 10 with 8). However, the level of A1 peptide in the 
supernatant is similar regardless of whether NEM is present in 
the lysis buffer (Fig. 1 A, compare lane 9 with 7). Thus, postly-
sis reduction of CT in the pellet does not trigger the release of 
the A1 chain to the supernatant.
To further verify the assay, we tested the fractionation 
pattern of a CT mutant whose A chain cannot be cleaved 
  because of a mutation at the cleavage site (R192H). Chloride 
secretion triggered by the R192H mutant is attenuated
dramatically (Lencer et al., 1997); thus, we anticipated that 
less of this toxin would arrive to the cytosol when compared 
with the wild-type toxin. Indeed, when cells were incubated 
with the R192H toxin, no toxin was found in the supernatant 
(Fig. 1 B, compare lane 3 with 1).
CT-stimulated chloride secretion was previously shown to 
be resistant to proteasome inactivation (Rodighiero et al., 2002), 
suggesting that the toxin escapes proteasomal degradation in 
the cytosol. As expected, proteasome inactivation with MG132, 
which was confi  rmed by the accumulation of polyubiquitinated 
proteins (Fig. 1 C, compare lane 2 with 1), did not signifi  cantly 
alter the toxin level in the cytosol (Fig. 1 C, top; compare lane 5 
with 3). The consistency of these results (Fig. 1) with previous 
chloride secretion studies (Lencer et al., 1997; Rodighiero et al., 
2002) validates the use of this semipermeabilized assay as a tool 
to study CT retrotranslocation directly.
Down-regulation of PDI-like proteins
We next tested whether PDI, an ER chaperone that unfolds the 
A and A1 chains in vitro (Tsai et al., 2001), plays a role in the 
Figure 1.  Retrotranslocation of the CTA1 subunit. 
(A) HeLa cells were incubated with CT for 90 min at 4 or 
37°C with or without BFA or NEM. Cells were permea-
bilized, centrifuged, and the supernatant and pellet 
fractions were separated, subjected to nonreducing 
SDS-PAGE, and immunoblotted with the indicated 
  antibodies. CTA, CTA1, and CTB are 28, 22, and 
11 kD, respectively. (B) As in A except a CT mutant, 
R192H, was used. PDI is 58 kD. (C) As in A except 
where indicated, cells were treated with MG132. 
Polyubiquitinated proteins range from 100 to 300 kD. 
White lines indicate that intervening lanes have been 
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ER–cytosol transport of CT. Our approach was to down- regulate 
PDI and other PDI-like proteins in cells using RNAi and test 
their effect on CT retrotranslocation. Of the 14 known human 
PDI-like proteins in the ER, we chose to down-regulate ERp72 
and ERp57 as controls because they are expressed at similar 
levels as PDI (unpublished data). PDI, ERp72, and ERp57 are 
characterized by the presence of a CxxC sequence within their 
thioredoxin domain (Fig. 2 A).  PDI (PDI
−), ERp72 (ERp72
−), 
and ERp57 (ERp57
−) were down-regulated in cells separately 
(Fig. 2 B, top); in each case, the expression of other PDI-like 
proteins (Fig. 2 B, bottom three panels) was unaffected. These 
results indicate that PDI, ERp72, and ERp57 expression can be 
reduced effi  ciently and specifi  cally.
We asked whether down-regulation of the PDI-like pro-
teins elicited the unfolded protein response, a cellular stress 
  response in which ER misfolded protein accumulation triggers 
the expression of ER chaperones such as BiP to alleviate protein 
misfolding. We found that BiP expression was only up- regulated 
marginally in PDI
−, ERp72
−, and ERp57
− cells compared 
with wild-type cells (Fig. 2 C, compare lanes 3, 5, and 7 with 1), 
indicating that the lack of these proteins did not signifi  cantly 
  induce the unfolded protein response. Moreover, the addition 
of tunicamycin, a drug that blocks N-glycosylation and, thus, 
causes the accumulation of misfolded proteins, induced BiP 
  expression in wild-type, PDI
−, ERp72
−, and ERp57
− cells 
(Fig. 2 C, compare lane 2 with 4, 6, and 8). We conclude that 
down-regulation of the PDI family proteins did not globally 
  disrupt ER function.
PDI and ERp72 play opposing roles during 
CT retrotranslocation
We assessed the effect of PDI down-regulation on the transport 
of CT to the cytosol by examining the toxin level in the super-
natant after cell fractionation. When cells were incubated with 
CT for 45 or 90 min, we found a decreased level of both the A 
and A1 chains from PDI
− cells when compared with wild-type 
cells (Fig. 3 A, top; compare lane 2 with 1 and lane 4 with 3; 
quantifi  ed as shown in the graphs). These data indicate that PDI 
facilitates toxin transport from the ER to the cytosol, which is 
consistent with our hypothesis that PDI-dependent unfolding of 
CT mediates the toxin’s retrotranslocation (Tsai et al., 2001). 
We note that a low A subunit level also appeared in the supernatant. 
This is unlikely to be caused by ER leakage, as ER markers and 
CTB (CT B subunit) were absent from this fraction. Thus, it is 
possible that although the A1 subunit is the preferred substrate 
for retrotranslocation, the A chain is also transported, albeit 
with lower effi  ciency.
In contrast, the A and A1 peptide level in the supernatant 
increased in ERp72
− cells when compared with wild-type cells 
(Fig. 3 A, top; compare lane 6 with lane 5 and lane 8 with 7; 
quantifi  ed as shown in the graphs), suggesting that ERp72 acts 
to retain CT in the ER, a reaction that opposes PDI’s function. 
The effects of down-regulating PDI and ERp72 on toxin trans-
port were also observed when NEM was present in the lysis 
buffer (unpublished data). In ERp57
− and wild-type cells, the 
toxin level in the supernatant was similar (Fig. 3 A, top; com-
pare lane 10 with 9 and lane 12 with 11). We conclude that the 
opposing effects of PDI and ERp72 on CT transport are specifi  c 
and are unlikely the result of a general disruption of ER chaper-
one functions.
To show that PDI and ERp72 did not affect CT traffi  cking 
to the ER, we used a variant of CT harboring consensus motifs 
for N-glycosylation on the B subunit (glycosylated CT [CT-GS]). 
Modifi  cation by N-glycosylation, detected by a molecular mass 
increase in the B subunit, indicates the toxin’s arrival to the ER. 
This toxin was previously used to show that CT is transported 
as a holotoxin from the plasma membrane to the ER (Fujinaga 
et al., 2003). Thus, N-glycosylation of the B subunit indicates 
the arrival of the A subunit to the ER. When cells were incu-
bated with CT-GS at 37°C and the cell lysate was analyzed 
by SDS-PAGE followed by immunoblotting with an antibody 
against the B subunit, a band larger than the nonglycosylated B 
subunit was observed (Fig. 3 B, lane 2). This band was shown 
previously to be N-glycanase sensitive (Fujinaga et al., 2003) 
and, thus, represents glycosylated B subunits. Glycosylated B 
subunits were not detected in cells incubated with the toxin at 
Figure 2.  Down-regulation of PDI-like proteins. (A) Structural 
organization of PDI, ERp72, and ERp57. (B) PDI, ERp72, 
ERp57, and ERp29 protein levels were examined in wild-type 
(WT), PDI
−, ERp72
−, and ERp57
− cells. (C) Wild-type, PDI
−, 
ERp72
−, and ERp57
− cells were incubated with 2 μg/ml 
  tunicamycin (TM) for 8 h, and BiP expression was assessed 
by SDS-PAGE and immunoblot analysis. BiP is 78 kD.JCB • VOLUME 173 • NUMBER 6 • 2006  856
4 or 37°C in the presence of BFA (Fig. 3 B, lanes 1 and 3). 
These experiments validate the use of CT-GS in monitoring 
A-subunit arrival to the ER. Signifi  cantly, the similar level of 
glycosylated B subunits found in wild-type, PDI
−, and ERp72
− 
cells (Fig. 3 B, lanes 4–6) indicate that PDI and ERp72 act on 
the toxin only after it reaches the ER. Furthermore, PDI and 
ERp72 down-regulation does not affect CT reduction (Fig. 3 C, 
compare lane 2 with 1 and lane 4 with 3).
Upon reaching the cytosol, the catalytic A1 subunit ADP 
ribosylates the Gαs protein, activating adenylate cyclase that, in 
turn, generates cAMP. Therefore, we measured the CT-induced 
cAMP response in PDI
− and ERp72
− cells. The CT-triggered 
cAMP level in PDI
− cells was 50% lower than in wild-type cells 
(Fig. 3 D, left). Forskolin, which stimulates adenylate cyclase 
directly, elicited a similar cAMP level in wild-type and PDI
− 
cells (unpublished data), indicating that PDI down-regulation 
did not affect adenylate cyclase. In contrast, the CT-induced 
cAMP level in ERp72
− cells was 40% higher than in wild-type 
cells (Fig. 3 D, right). This result was normalized against the 
forskolin-induced cAMP response, as forskolin also triggered a 
higher cAMP response in ERp72
− cells. The higher forskolin-
induced cAMP response in these cells is likely caused by a con-
comitant increase in cell surface expression of adenylate cyclase 
(unpublished data). Thus, the cAMP data are consistent with the 
ER–cytosol transport assay—namely that PDI retrotranslocates 
CT, whereas ERp72 retains the toxin in the ER.
Opposing effects of PDI and ERp72 
on CT conformation
PDI’s ability to unfold CT (Tsai et al., 2001) is consistent with 
its role in toxin retrotranslocation. ERp72’s role in facilitating 
ER retention suggests that it may recognize CT as a misfolded 
protein and attempt to “refold” the toxin’s structure. Incubation
of purifi  ed PDI but not the control protein BSA with CTA 
(CT A subunit) was shown previously to render the A and A1 
chains sensitive to trypsin digestion (Fig. 4 B, compare lane 
2 with 1; Tsai et al., 2001), indicating that PDI unfolded the 
toxin. Purifi  ed ERp72 (Fig. 4 A) did not cause the toxin to 
Figure 3.  PDI and ERp72 exert opposing effects on 
CT retrotranslocation. (A, top) Wild-type (WT), PDI
−, 
ERp72
−, and ERp57
− cells were incubated with CT 
for 45 or 90 min, permeabilized, and the supernatant 
fraction was analyzed as in Fig. 1. (bottom) The inten-
sities of the CTA and CTA1 bands in the supernatant 
were quantiﬁ  ed. Graphs show the mean ± SD (error 
bars) of two to four experiments. (B) Wild-type, PDI
−, 
and ERp72
− cells were incubated with CT-GS, and the 
cell lysate was subjected to SDS-PAGE followed by 
immunoblotting with an anti-CTB antibody. Nonglyco-
sylated and glycosylated CTB are 17 and 21 kD, re-
spectively. (C) Whole cell lysates from CT-intoxicated 
wild-type, PDI
−, and ERp72
− cells were prepared in 
the presence of NEM and subjected to immunoblot-
ting with CTA antibody. (D) Wild-type, PDI
−, and 
ERp72
− cells were incubated with CT for 45 or 90 min, 
and the cAMP level was measured by a cAMP 
Biotrak Enzyme Immunoassay System (GE Healthcare). 
Means ± SD of two to four experiments are shown. 
White lines indicate that intervening lanes have been 
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become protease sensitive (not depicted). We now fi  nd that 
regardless of PDI’s presence, a higher trypsin concentration 
rendered the A and A1 chains sensitive to degradation (Fig. 4 B, 
compare lanes 3 and 4 with 1). However, under this condi-
tion, ERp72 protected the toxin from degradation (Fig. 4 B, 
compare lane 5 with 3 and 4), indicating that ERp72 alters 
CT’s conformation to render it more folded and compact. 
 Alternatively, it is possible that ERp72 protects the toxin against 
protease digestion by either stabilizing the native conformation 
of the toxin or interacting with CT in a similar manner as PDI 
but with reduced effi  ciency. Nonetheless, PDI and ERp72’s 
  opposing effects on CT’s conformation likely refl  ect their roles 
in facilitating retrotranslocation and ER retention during ER 
quality control.
A general role of PDI and ERp72 in quality 
control of ER misfolded proteins
Do the opposing functions of PDI and ERp72 represent a gen-
eral mechanism operating in the ER? We developed a method 
to measure the bulk arrival of misfolded proteins from the ER 
to the cytosol. Upon reaching the cytosolic surface of the ER 
membrane, ER misfolded polypeptides are polyubiquitinated 
before being targeted for proteasomal degradation (for review 
see Tsai et al., 2002). Consequently, proteasome inactivation 
ought to lead to the accumulation of polyubiquitinated ER mis-
folded proteins as well as cytosolic proteins. The effect of ER 
resident protein down-regulation on the accumulation of total 
polyubiquitinated proteins should, therefore, refl  ect their role in 
the ER–cytosol transport process. We measured the level of 
Figure 4.  Opposing effects of PDI and ERp72 on the confor-
mation of CT. (A) His-tagged ERp72 protein was puriﬁ  ed from 
bacteria and analyzed by SDS-PAGE followed by Coomassie 
staining or immunoblotting with an antibody against ERp72. 
(B) CTA was incubated with BSA, PDI, or ERp72   followed by 
the addition of trypsin. Samples were subjected to SDS-PAGE 
followed by immunoblotting with an anti-CTA antibody.
Figure 5.  A general role of PDI and ERp72 in 
the retrotranslocation of ER misfolded proteins. 
(A, top) Wild-type (WT), PDI
−, or ERp72
− cells 
were treated with MG132, and the cell lysate 
was subjected to SDS-PAGE followed by immuno-
blotting with the indicated antibodies. (bottom) 
The total ubiquitin signal intensity was measured. 
Graphs show the mean ± SD (error bars) 
of three to ﬁ   ve experiments. (B) Wild-type, 
PDI
−, or ERp72
− cells were treated with TNFα, 
and the lysate was subjected to SDS-PAGE 
  followed by immunoblotting with an antibody 
against IκBα. IκBα is 39 kD. (C) CHO cells 
  stably expressing cogTg (CHO-P) and PDI 
(CHO-PDI) or ERp72 (CHO-ERp72) were pulse 
labeled with [
35S]methionine and chased for 
the times indicated. CogTg was immunopre-
cipitated from the cell lysate with anti-Tg anti-
body and analyzed by SDS-PAGE. Data show 
quantiﬁ  cation of the radioactive cogTg band 
intensity. (D) Diagram depicting the similarity 
between the quality control system in the ER 
and cytosol. See last paragraph of Results and 
discussion. White lines indicate that interven-
ing lanes have been spliced out.JCB • VOLUME 173 • NUMBER 6 • 2006  858
polyubiquitinated proteins and found that incubation of cells 
with the proteasome inhibitor MG132 resulted in an increase of 
polyubiquitinated proteins (Fig. 5 A, compare lane 3 with 1 and 
lane 7 with 5). However, in PDI
− cells, less MG132-induced 
polyubiquitinated proteins appeared when compared with wild-
type cells (Fig. 5 A, compare lane 4 with 3; quantifi  ed as shown 
in the graphs), whereas in ERp72
− cells, more polyubiquitinated 
proteins were present (Fig. 5 A, compare lane 8 with 7; quanti-
fi  ed as shown in the graphs). Although the source of the poly-
ubiquitinated proteins is unclear, they likely originated from the 
ER. Quantifi  cation showed that although PDI down-regulation 
reduced the total level of polyubiquitinated proteins by  40%, 
a signifi  cant portion ( 60%) was unaffected; the unaffected 
polyubiquitinated proteins are presumably cytosolic proteins.
We then asked whether cytosolic ubiquitination reactions 
are affected nonspecifi  cally by PDI and ERp72 down- regulation. 
IκBα is a cytosolic protein that is polyubiquitinated in   response 
to TNFα stimulation before being degraded by the proteasome 
(for review see Karin and Ben-Neriah, 2000). Indeed, we found 
that IκBα was degraded with similar effi  ciency upon TNFα 
treatment in wild-type, PDI
−, and ERp72
− cells (Fig. 5 B, com-
pare lanes 4–6 with 1–3), suggesting that IκBα ubiquitination 
was not disrupted by PDI and ERp72 down-regulation. These 
fi   ndings indicate that PDI facilitates the retrotranslocation 
of some ER misfolded proteins, whereas ERp72 mediates their 
ER retention.
We further characterized this effect on a specifi  c ER mis-
folded substrate. Thyroglobulin (Tg), the thyroid prohormone, 
is synthesized and folded in the ER before being secreted. A 
mutant form of Tg, cogTg, was shown previously to undergo 
retrotranslocation and proteasomal degradation (Tokunaga et al., 
2000). PDI overexpression in CHO cells stably expressing 
cogTg (CHO-PDI) stimulated the rate of cogTg degradation 
when compared with parental CHO cells expressing cogTg 
(CHO-P; Fig. 5 C, compare open with closed squares). In con-
trast, ERp72 overexpression in CHO cells (CHO-ERp72) de-
creased the rate of cogTg degradation (Fig. 5 C, compare open 
squares with circles). These results suggest that PDI stimulates 
the ER–cytosol transport of cogTg, whereas ERp72 retains it 
in the ER. We conclude that PDI and ERp72’s opposing roles 
  operate not only on CT retrotranslocation but more generally 
for ER misfolded proteins.
The role of PDI and ERp72 
in retrotranslocation and ER retention
How do chaperones that belong to the same family serve oppo-
site functions? PDI possesses two thioredoxin domains contain-
ing the redox-active CxxC motif (Fig. 2 A, CxxC box) and two 
thioredoxin-like domains without the CxxC motif (Fig. 2 A, 
white rectangles), whereas ERp72 contains three redox-active 
and two redox-inactive domains (Fig. 2 B). Their major differ-
ence is that PDI contains an additional c domain that is absent 
in ERp72. It is possible that this domain participates in the un-
folding of polypeptides. Interestingly, PDI but not ERp72 was 
implicated in the unfolding of the nonnative structure of bovine 
pancreatic trypsin inhibitor during disulfi  de bond rearrange-
ment (Weissman and Kim, 1993; Satoh et al., 2005), supporting 
our conclusion that PDI specifi  cally unfolds misfolded substrates. 
PDI has also been shown to facilitate the proteasomal degradation 
of ER misfolded proteins in yeast (Gillece et al., 1999), a process 
that presumably requires substrate unfolding and retrotrans-
location. Our fi  ndings that ERp72 mediates the ER retention 
of CT and misfolded proteins are consistent with recent data 
demonstrating that ER retention of a misfolded secretory 
  (Cotterill et al., 2005) and a transmembrane protein (Sorensen 
et al., 2005) is coincident with binding to ERp72.
ERp72 and PDI’s dedicated roles in ER quality control 
appear analogous to the cytosolic chaperone system that func-
tions in protein folding and degradation (Fig. 5 D; McClellan 
et al., 2005). In this case, the chaperones Hsp70 and TriC assist 
in protein folding, whereas the Hsp70–Hsp90–Sti1–Sse1 com-
plex mediates protein degradation. As PDI can promote protein 
folding and unfolding reactions, it is possible that PDI cofactors 
exist to control these opposing processes, which is similar to 
Hsp70 regulation.
Materials and methods
Materials
Antibodies against PDI, BiP, and Hsp90 were purchased from Santa Cruz 
Biotechnology, Inc. Antibodies against ERp72 were obtained from Stress-
Gen Biotechnologies, antibodies against ubiquitin were purchased from 
Zymed Laboratories, and antibodies against IκBα were obtained from 
  Biolegend. CT A and B antibodies and CT-GS were provided by the Lencer 
laboratory, the Tg antibodies were obtained from the Arvan laboratory, 
and the CT R192H mutant was provided by R. Holmes (University of Colo-
rado, Boulder, CO). Hsp27, ERp57, and ERp29 antibodies were gifts from 
M. Welsh (University of Michigan, Ann Arbor, MI), S. High (University of 
Manchester, Manchester, England), and S. Mkrtchian (Karolinska Institutet, 
Stockholm, Sweden), respectively. CT, CTA, and PDI were purchased from 
Calbiochem. Mouse ERp72 cDNA was subcloned into pQE30, and the 
protein was puriﬁ  ed using a Ni–nitrilotriacetic acid agarose column.
Protein down-regulation
PDI-speciﬁ  c (5′-G  A  C  C  T  C  C  C  C  T  T  C  A  A  A  G  T  T  G  T  T  -3′) siRNA was synthesized 
by Ambion, and ERp72- (5′-C  A  A  G  C  G  U  U  C  U  C  C  U  C  C  A  A  U  U  T  T  -3′) and 
ERp57-speciﬁ  c (5′-U  G  A  A  G  G  U  G  G  C  C  G  UGAAUUATT-3′) siRNAs were syn-
thesized by Invitrogen. 10 nM duplexed siRNA was transfected into HeLa 
cells using Oligofectamine (Invitrogen) according to the manufacturer’s 
protocol. Protein expression was assessed by SDS-PAGE and immunoblot 
analysis. Experiments were initiated 48 (ERp57) or 72 h (PDI and ERp72) 
after transfection.
Retrotranslocation assay
Cells were incubated with 10 nM CT in HBSS at 37°C for 45 or 90 min. 
For permeabilization, 2 × 10
6 cells were resuspended in 100 μl of 0.04% 
digitonin in HCN buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 2 mM 
CaCl2, and protease inhibitors) with or without 10 mM NEM, incubated on 
ice for 10 min, and centrifuged at 16,000 g for 10 min. The supernatant 
was removed, and the pellet was washed with PBS and resuspended in 
100 μl of the original buffer. Fractions were analyzed by nonreducing 
SDS-PAGE and immunoblot analysis. Where indicated, cells were treated 
with 2 μM MG132 for 90 min.
N-glycosylation of CTB
HeLa cells were incubated with 50 nM CT-GS in HBSS for 3 h at 4 or 37°C 
in the presence or absence of 5 μg/ml BFA. Cells were harvested in TN 
  lysis buffer (1% Triton X-100, 1.75% n-octyl-B-/d-glucopyranoside, 10 mM 
Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, and protease inhibitors), and 
the lysates were analyzed for the presence of glycosylated CTB.
cAMP assay
A cAMP enzyme immunoassay system (GE Healthcare) was used to quan-
tify cAMP synthesis induced by 10 nM CT or 50 μM forskolin in HBSS. 
Samples were assayed in duplicate, and the mean optical density was PDI-LIKE PROTEINS FUNCTION IN ER QUALITY CONTROL • FORSTER ET AL. 859
used to calculate the cAMP level/well. The cAMP response was deter-
mined by dividing the cAMP level in CT- or forskolin -treated cells by the 
cAMP level in unstimulated cells. Forskolin induced a sevenfold higher 
cAMP response in ERp72
− cells than in wild-type cells. Results are reported 
as a percentage of the wild-type CT-induced cAMP response normalized to 
the forskolin-induced cAMP response.
Trypsin sensitivity assay
Puriﬁ  ed CTA was incubated with 1 mM glutathione, 2 μg/ml BSA, 2 μg/ml 
PDI, or 0.2 μg/ml ERp72 for 30 min at 37°C. 100 or 300 μg/ml trypsin 
was added to the samples for 30 min at 4°C. Samples were analyzed by 
nonreducing SDS-PAGE followed by immunoblot analysis.
Accumulation of polyubiquitinated proteins
Cells were incubated with or without 20 μM MG132 for 30 min and lysed 
in a buffer containing 1% Triton-X, 10 mM NEM, 30 mM Hepes, pH 7.4, 
150 mM NaCl, 5 mM EDTA, and protease inhibitors. Cleared lysates were 
analyzed by 4–20% SDS-PAGE followed by immunoblot analysis. To 
  monitor ubiquitin-dependent degradation of IκBα, cells were treated with 
10 ng/ml TNFα for 15 min, and the cell lysate was analyzed for the pres-
ence of IκBα.
Pulse-chase analysis
The cogTg degradation rate was analyzed as previously described 
  (Tokunaga et al., 2000).
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